Literature DB >> 11523701

Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy?

L Cristofori1, B Tavazzi, R Gambin, R Vagnozzi, C Vivenza, A M Amorini, D Di Pierro, G Fazzina, G Lazzarino.   

Abstract

BACKGROUND: On the basis of the contradiction between data on experimental head trauma showing oxidative stress-mediated cerebral tissue damage and failure of the majority of clinical trials using free radical scavenger drugs, we monitored the time-course changes of malondialdehyde (MDA, an index of cell lipid peroxidation), ascorbate, and dephosphorylated ATP catabolites in cerebrospinal fluid (CSF) of traumatic brain-injured patients.
METHODS: CSF samples were obtained from 20 consecutive patients suffering from severe brain injury. All patients were comatose, with a Glasgow Coma Scale on admission of 6 +/- 1. The first CSF sample for each patient was collected within a mean value of 2.95 hours from trauma (SD=1.98), after the insertion of a ventriculostomy catheter for the continuous monitoring of intracranial pressure. During the next 48 hours, CSF was withdrawn from each patient once every 6 hours. All samples were analyzed by an ion-pairing high-performance liquid chromatographic method for the simultaneous determination of MDA, ascorbic acid, hypoxanthine, xanthine, uric acid, inosine, and adenosine.
RESULTS: In comparison with values recorded in 10 herniated-lumbar-disk, noncerebral control patients, data showed that all CSF samples of brain-injured patients had high values (0.226 micromol/L; SD=0.196) of MDA (undetectable in samples of control patients) and decreased ascorbate levels (96.25 micromol/L; SD=31.74), already at the time of first withdrawal at the time of hospital admission. MDA was almost constant in the next two withdrawals and tended to decrease thereafter, although 48 hours after hospital admission, a mean level of 0.072 micromol/L CSF (SD=0.026) was still recorded. The ascorbate level was normalized 42 hours after hospital admission. Changes in the CSF values of ATP degradation products (oxypurines and nucleosides) suggested a dramatic alteration of neuronal energy metabolism after traumatic brain injury.
CONCLUSIONS: On the whole, these data demonstrate the early onset of oxygen radical-mediated oxidative stress, proposing a valid explanation for the failure of clinical trials based on the administration of oxygen free radical scavenger drugs and suggesting a possible rationale for testing the efficacy of lipid peroxidation "chain breakers" in future clinical trials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523701     DOI: 10.2310/6650.2001.33790

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  20 in total

Review 1.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

2.  Global assessment of oxidized free fatty acids in brain reveals an enzymatic predominance to oxidative signaling after trauma.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew A Amoscato; Jesse Lewis; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-25       Impact factor: 5.187

3.  Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.

Authors:  Giacomo Lazzarino; Angela M Amorini; Axel Petzold; Claudio Gasperini; Serena Ruggieri; Maria Esmeralda Quartuccio; Giuseppe Lazzarino; Enrico Di Stasio; Barbara Tavazzi
Journal:  Mol Neurobiol       Date:  2016-11-08       Impact factor: 5.590

4.  Neuroprotective effects of caffeic acid phenethyl ester on experimental traumatic brain injury in rats.

Authors:  Memduh Kerman; Mehmet Kanter; Kerim Kenan Coşkun; Mustafa Erboga; Ahmet Gurel
Journal:  J Mol Histol       Date:  2011-11-29       Impact factor: 2.611

5.  The effects of memantine on lipid peroxidation following closed-head trauma in rats.

Authors:  Hakan Ozsüer; Aşkin Görgülü; Talat Kiriş; Sabahattin Cobanoğlu
Journal:  Neurosurg Rev       Date:  2005-01-26       Impact factor: 3.042

Review 6.  Emerging therapies in traumatic brain injury.

Authors:  Patrick M Kochanek; Travis C Jackson; Nikki Miller Ferguson; Shaun W Carlson; Dennis W Simon; Erik C Brockman; Jing Ji; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Anthony E Kline; Philip E Empey; Robert S B Clark; Edwin K Jackson; C Edward Dixon
Journal:  Semin Neurol       Date:  2015-02-25       Impact factor: 3.420

7.  Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.

Authors:  Leonardo Lorente; María M Martín; Pedro Abreu-González; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; José M Lorenzo; Ismael Molina; Alejandro Jiménez
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

Review 8.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 9.  Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.

Authors:  Clifford L Eastman; Raimondo D'Ambrosio; Thota Ganesh
Journal:  Neuropharmacology       Date:  2019-12-06       Impact factor: 5.250

Review 10.  New Prognostic Biomarkers in Patients With Traumatic Brain Injury.

Authors:  Leonardo Lorente
Journal:  Arch Trauma Res       Date:  2015-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.